Buy the MiniMedTM 670G.
You'll be automatically enrolled into Next Tech Pathway as part of your purchase.
When new technology is available, we'll notify you that it's time to upgrade.
Once you confirm you are ready to move forward, we'll ship you a new device and you'll send us back your MiniMedTM 670G pump and transmitter.
Our pump and continuous glucose monitor (CGM) work together to:
If you've been considering a change, this could be a great time to make the move to our latest technology. Fill out the form to learn more.
The MiniMed 670G system is intended for the management of Type 1 diabetes in persons age seven and older.
Δ Refers to Auto Mode. Some user interaction required. Individual results may vary.
# Based on sensor glucose.
1. Bergenstal R, Garg S, Weinzimer S, et al. Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA. 2016;316(13):1407–1408.
*Terms and Conditions
The Next Tech Pathway program (the “Program”) allows eligible, enrolled participants whose MiniMed™ 670G system order is shipped starting on 09/01/20 (Sept 1, 2020) to be included. The last day to place an order is 01/31/21 (January 31, 2021). This Program allows for an upgrade to our next MiniMed™ system at $0 once licensed by Health Canada. Eligibility dates subject to change.
To be eligible for the Program, participants must purchase a MiniMed™ 670G system and meet one of the following requirements:
To upgrade through the Program, all participants must agree and are subject to these terms and conditions: